Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Clearside Biomedical Inc
CLSD | US
1.32
USD0.17
14.78%
CLSD | US
About Clearside Biomedical Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.32
Open
1.14
High
1.32
Low
1.14
Clearside Biomedical Inc. a biopharmaceutical company focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX an axitinib injectable suspension for suprachoroidal injection which is in Phase 1/2a clinical trial; and CLS-301 an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical Inc. has a collaboration with Bausch Health Arctic Vision REGENXBIO Inc. and Aura Biosciences. The company was incorporated in 2011 and is headquartered in Alpharetta Georgia.
View LessCLSD | US
Risk
107.2
Sharpe
0.55
Luna's Score
46/100
Recommendation
Hold
Luna says (CLSD | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
120.2%1 month
107.2%3 months
79.6%6 months
74.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.93
Debt to equity
-1.68
Debt to assets
1.40
Ent. to EBITDA
-2.84
Ent. to rev.
7.64
PEG
-
Other Fundamentals
EBITDA
-25.66M
MarketCap
101.31M
MarketCap(USD)
101.31M
Div. yield
-
Op. margin
-8.43K
Erngs. growth
-
Rev. growth
-91.20
Ret. on equity
-1.31K
Short ratio
0.65
Short perc.
0.37
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.60
Range1M
0.60
Range3M
0.73
Volumes: Market Activity
Rel. volume
1.35
Price X volume
2.93M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.84 | - | Cheaper |
| Ent. to Revenue | 7.64 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.93 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 79.57 | - | Par |
| Debt to Equity | -1.68 | -1.23 | Cheaper |
| Debt to Assets | 1.40 | 0.25 | Expensive |
| Market Cap | 101.31M | - | Emerging |
